Top compounds associated with response to CLDN34


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.024 0.5
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.5
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.5
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.027 0.5
mRNA methylstat CTRPv2 pan-cancer AAC 0.031 0.5
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.027 0.5
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.054 0.5
mRNA MI-2 CTRPv2 pan-cancer AAC 0.039 0.5
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
Download CSV